Back to Search
Start Over
Reply to 'Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211'
- Source :
- Pharmaceutics, Vol 12, Iss 822, p 822 (2020), Pharmaceutics
- Publication Year :
- 2020
- Publisher :
- MDPI AG, 2020.
-
Abstract
- The paper entitled “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211” discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...]
- Subjects :
- Reply
Budesonide
medicine.medical_specialty
business.industry
Pharmaceutical Science
lcsh:RS1-441
02 engineering and technology
respiratory system
021001 nanoscience & nanotechnology
medicine.disease
030226 pharmacology & pharmacy
Gastroenterology
lcsh:Pharmacy and materia medica
03 medical and health sciences
0302 clinical medicine
n/a
Internal medicine
medicine
Pharmaceutics
0210 nano-technology
Eosinophilic esophagitis
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 19994923
- Volume :
- 12
- Issue :
- 822
- Database :
- OpenAIRE
- Journal :
- Pharmaceutics
- Accession number :
- edsair.doi.dedup.....8f5e0c8c5b1751115b6f725b45d0244e